Selected research
Industry Research
Magnesium Sulfate Injection Industry Research Report 2026
Market perspective
The global Magnesium Sulfate Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Magnesium Sulfate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Magnesium Sulfate Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Magnesium Sulfate Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Magnesium Sulfate Injection include AdvaCare Pharma, American Regent, Exela, WG Critical Care, X-Gen, Beijing Yimin Pharmaceutical, Chengdu Brilliant Pharmaceutical, Fresenius Kabi and Sinopharm Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Magnesium Sulfate Injection market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Magnesium Sulfate Injection Market by Company
AdvaCare Pharma
American Regent
Exela
WG Critical Care
X-Gen
Beijing Yimin Pharmaceutical
Chengdu Brilliant Pharmaceutical
Fresenius Kabi
Sinopharm Group
Hangzhou Minsheng Pharmaceutical Industry Group
Hebei Tiancheng Pharmaceutical
Pfizer
Jiangsu Huayang Pharmacy
Jinling Pharmaceutical
Shanghai Xudong Help
Wuhan Jiuan Pharmaceutical
Magnesium Sulfate Injection Segment by Type
500mg/ml
40mg/ml
250mg/ml
10mg/ml
Others
Magnesium Sulfate Injection Segment by Application
Clinics
Hospital
Recovery Center
Magnesium Sulfate Injection Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Magnesium Sulfate Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Magnesium Sulfate Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Magnesium Sulfate Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Magnesium Sulfate Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Magnesium Sulfate Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Magnesium Sulfate Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 500mg/ml
- 40mg/ml
- 250mg/ml
- 10mg/ml
- Others
Applications
- Clinics
- Hospital
- Recovery Center
Companies covered
- AdvaCare Pharma
- American Regent
- Exela
- WG Critical Care
- X-Gen
- Beijing Yimin Pharmaceutical
- Chengdu Brilliant Pharmaceutical
- Fresenius Kabi
- Sinopharm Group
- Hangzhou Minsheng Pharmaceutical Industry Group
- Hebei Tiancheng Pharmaceutical
- Pfizer
- Jiangsu Huayang Pharmacy
- Jinling Pharmaceutical
- Shanghai Xudong Help
- Wuhan Jiuan Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Magnesium Sulfate Injection Market Size (2021-2032)
- 2.2.2 Global Magnesium Sulfate Injection Sales (2021-2032)
- 2.2.3 Global Magnesium Sulfate Injection Market Average Price (2021-2032)
- 2.3 Magnesium Sulfate Injection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 500mg/ml
- 2.3.3 40mg/ml
- 2.3.4 250mg/ml
- 2.3.5 10mg/ml
- 2.3.6 Others
- 2.4 Magnesium Sulfate Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Clinics
- 2.4.3 Hospital
- 2.4.4 Recovery Center
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Magnesium Sulfate Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Magnesium Sulfate Injection Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Magnesium Sulfate Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global Magnesium Sulfate Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global Magnesium Sulfate Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Magnesium Sulfate Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Magnesium Sulfate Injection, Product Type & Application
- 3.8 Global Manufacturers of Magnesium Sulfate Injection, Established Date
- 3.9 Global Magnesium Sulfate Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 AdvaCare Pharma
- 4.1.1 AdvaCare Pharma Company Information
- 4.1.2 AdvaCare Pharma Business Overview
- 4.1.3 AdvaCare Pharma Magnesium Sulfate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 AdvaCare Pharma Magnesium Sulfate Injection Product Portfolio
- 4.1.5 AdvaCare Pharma Recent Developments
- 4.2 American Regent
- 4.2.1 American Regent Company Information
- 4.2.2 American Regent Business Overview
- 4.2.3 American Regent Magnesium Sulfate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 American Regent Magnesium Sulfate Injection Product Portfolio
- 4.2.5 American Regent Recent Developments
- 4.3 Exela
- 4.3.1 Exela Company Information
- 4.3.2 Exela Business Overview
- 4.3.3 Exela Magnesium Sulfate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Exela Magnesium Sulfate Injection Product Portfolio
- 4.3.5 Exela Recent Developments
- 4.4 WG Critical Care
- 4.4.1 WG Critical Care Company Information
- 4.4.2 WG Critical Care Business Overview
- 4.4.3 WG Critical Care Magnesium Sulfate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 WG Critical Care Magnesium Sulfate Injection Product Portfolio
- 4.4.5 WG Critical Care Recent Developments
- 4.5 X-Gen
- 4.5.1 X-Gen Company Information
- 4.5.2 X-Gen Business Overview
- 4.5.3 X-Gen Magnesium Sulfate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 X-Gen Magnesium Sulfate Injection Product Portfolio
- 4.5.5 X-Gen Recent Developments
- 4.6 Beijing Yimin Pharmaceutical
- 4.6.1 Beijing Yimin Pharmaceutical Company Information
- 4.6.2 Beijing Yimin Pharmaceutical Business Overview
- 4.6.3 Beijing Yimin Pharmaceutical Magnesium Sulfate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Beijing Yimin Pharmaceutical Magnesium Sulfate Injection Product Portfolio
- 4.6.5 Beijing Yimin Pharmaceutical Recent Developments
- 4.7 Chengdu Brilliant Pharmaceutical
- 4.7.1 Chengdu Brilliant Pharmaceutical Company Information
- 4.7.2 Chengdu Brilliant Pharmaceutical Business Overview
- 4.7.3 Chengdu Brilliant Pharmaceutical Magnesium Sulfate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Chengdu Brilliant Pharmaceutical Magnesium Sulfate Injection Product Portfolio
- 4.7.5 Chengdu Brilliant Pharmaceutical Recent Developments
- 4.8 Fresenius Kabi
- 4.8.1 Fresenius Kabi Company Information
- 4.8.2 Fresenius Kabi Business Overview
- 4.8.3 Fresenius Kabi Magnesium Sulfate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Fresenius Kabi Magnesium Sulfate Injection Product Portfolio
- 4.8.5 Fresenius Kabi Recent Developments
- 4.9 Sinopharm Group
- 4.9.1 Sinopharm Group Company Information
- 4.9.2 Sinopharm Group Business Overview
- 4.9.3 Sinopharm Group Magnesium Sulfate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Sinopharm Group Magnesium Sulfate Injection Product Portfolio
- 4.9.5 Sinopharm Group Recent Developments
- 4.10 Hangzhou Minsheng Pharmaceutical Industry Group
- 4.10.1 Hangzhou Minsheng Pharmaceutical Industry Group Company Information
- 4.10.2 Hangzhou Minsheng Pharmaceutical Industry Group Business Overview
- 4.10.3 Hangzhou Minsheng Pharmaceutical Industry Group Magnesium Sulfate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Hangzhou Minsheng Pharmaceutical Industry Group Magnesium Sulfate Injection Product Portfolio
- 4.10.5 Hangzhou Minsheng Pharmaceutical Industry Group Recent Developments
- 4.11 Hebei Tiancheng Pharmaceutical
- 4.11.1 Hebei Tiancheng Pharmaceutical Company Information
- 4.11.2 Hebei Tiancheng Pharmaceutical Business Overview
- 4.11.3 Hebei Tiancheng Pharmaceutical Magnesium Sulfate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Hebei Tiancheng Pharmaceutical Magnesium Sulfate Injection Product Portfolio
- 4.11.5 Hebei Tiancheng Pharmaceutical Recent Developments
- 4.12 Pfizer
- 4.12.1 Pfizer Company Information
- 4.12.2 Pfizer Business Overview
- 4.12.3 Pfizer Magnesium Sulfate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Pfizer Magnesium Sulfate Injection Product Portfolio
- 4.12.5 Pfizer Recent Developments
- 4.13 Jiangsu Huayang Pharmacy
- 4.13.1 Jiangsu Huayang Pharmacy Company Information
- 4.13.2 Jiangsu Huayang Pharmacy Business Overview
- 4.13.3 Jiangsu Huayang Pharmacy Magnesium Sulfate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Jiangsu Huayang Pharmacy Magnesium Sulfate Injection Product Portfolio
- 4.13.5 Jiangsu Huayang Pharmacy Recent Developments
- 4.14 Jinling Pharmaceutical
- 4.14.1 Jinling Pharmaceutical Company Information
- 4.14.2 Jinling Pharmaceutical Business Overview
- 4.14.3 Jinling Pharmaceutical Magnesium Sulfate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Jinling Pharmaceutical Magnesium Sulfate Injection Product Portfolio
- 4.14.5 Jinling Pharmaceutical Recent Developments
- 4.15 Shanghai Xudong Help
- 4.15.1 Shanghai Xudong Help Company Information
- 4.15.2 Shanghai Xudong Help Business Overview
- 4.15.3 Shanghai Xudong Help Magnesium Sulfate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Shanghai Xudong Help Magnesium Sulfate Injection Product Portfolio
- 4.15.5 Shanghai Xudong Help Recent Developments
- 4.16 Wuhan Jiuan Pharmaceutical
- 4.16.1 Wuhan Jiuan Pharmaceutical Company Information
- 4.16.2 Wuhan Jiuan Pharmaceutical Business Overview
- 4.16.3 Wuhan Jiuan Pharmaceutical Magnesium Sulfate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Wuhan Jiuan Pharmaceutical Magnesium Sulfate Injection Product Portfolio
- 4.16.5 Wuhan Jiuan Pharmaceutical Recent Developments
5 Global Magnesium Sulfate Injection Market Scenario by Region
- 5.1 Global Magnesium Sulfate Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Magnesium Sulfate Injection Sales by Region: 2021-2032
- 5.2.1 Global Magnesium Sulfate Injection Sales by Region: 2021-2026
- 5.2.2 Global Magnesium Sulfate Injection Sales by Region: 2027-2032
- 5.3 Global Magnesium Sulfate Injection Revenue by Region: 2021-2032
- 5.3.1 Global Magnesium Sulfate Injection Revenue by Region: 2021-2026
- 5.3.2 Global Magnesium Sulfate Injection Revenue by Region: 2027-2032
- 5.4 North America Magnesium Sulfate Injection Market Facts & Figures by Country
- 5.4.1 North America Magnesium Sulfate Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Magnesium Sulfate Injection Sales by Country (2021-2032)
- 5.4.3 North America Magnesium Sulfate Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Magnesium Sulfate Injection Market Facts & Figures by Country
- 5.5.1 Europe Magnesium Sulfate Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Magnesium Sulfate Injection Sales by Country (2021-2032)
- 5.5.3 Europe Magnesium Sulfate Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Magnesium Sulfate Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Magnesium Sulfate Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Magnesium Sulfate Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Magnesium Sulfate Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Magnesium Sulfate Injection Market Facts & Figures by Country
- 5.7.1 South America Magnesium Sulfate Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Magnesium Sulfate Injection Sales by Country (2021-2032)
- 5.7.3 South America Magnesium Sulfate Injection Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Magnesium Sulfate Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Magnesium Sulfate Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Magnesium Sulfate Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Magnesium Sulfate Injection Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Magnesium Sulfate Injection Sales by Type (2021-2032)
- 6.1.1 Global Magnesium Sulfate Injection Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Magnesium Sulfate Injection Sales Market Share by Type (2021-2032)
- 6.2 Global Magnesium Sulfate Injection Revenue by Type (2021-2032)
- 6.2.1 Global Magnesium Sulfate Injection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Magnesium Sulfate Injection Revenue Market Share by Type (2021-2032)
- 6.3 Global Magnesium Sulfate Injection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Magnesium Sulfate Injection Sales by Application (2021-2032)
- 7.1.1 Global Magnesium Sulfate Injection Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Magnesium Sulfate Injection Sales Market Share by Application (2021-2032)
- 7.2 Global Magnesium Sulfate Injection Revenue by Application (2021-2032)
- 7.2.1 Global Magnesium Sulfate Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Magnesium Sulfate Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global Magnesium Sulfate Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Magnesium Sulfate Injection Value Chain Analysis
- 8.1.1 Magnesium Sulfate Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Magnesium Sulfate Injection Production Mode & Process
- 8.2 Magnesium Sulfate Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Magnesium Sulfate Injection Distributors
- 8.2.3 Magnesium Sulfate Injection Customers
9 Global Magnesium Sulfate Injection Analyzing Market Dynamics
- 9.1 Magnesium Sulfate Injection Industry Trends
- 9.2 Magnesium Sulfate Injection Industry Drivers
- 9.3 Magnesium Sulfate Injection Industry Opportunities and Challenges
- 9.4 Magnesium Sulfate Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst